AMERICAN COLLEGE OF TOXICOLOGY

EIN: 363007817 501(c)(3)

RESTON, VA

Total Revenue
$3,259,122
Total Expenses
$2,574,057
Total Assets
$8,385,806
Net Assets
$8,036,536
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1977
Legal Domicile
IL
Principal Officer
ELISA TURNER
Phone
7035470875
Tax Period
2025-01-01 to 2025-12-31

AMERICAN COLLEGE OF TOXICOLOGY, founded in 1977, is a community nonprofit that reported $3.3M in total revenue in fiscal year 2025. Revenue grew 17% year-over-year, indicating healthy expansion. The organization ran a surplus of $685K, a strong 21% operating margin.

Mission

THE MISSION OF THE AMERICAN COLLEGE OF TOXICOLOGY IS TO EDUCATE, LEAD, AND SERVE PROFESSIONALS IN TOXICOLOGY AND RELATED DISCIPLINES BY PROMOTING THE EXCHANGE OF INFORMATION AND PERSPECTIVES ON APPLIED TOXICOLOGY AND SAFETY ASSESSMENT.

Program Service Accomplishments

Program 1
Expenses: $1,252,188 Revenue: $1,889,955

ANNUAL MEETING AND AWARDS THE 46TH ANNUAL MEETING WAS HELD IN PHOENIX, ARIZONA AND WAS ATTENDED BY 1,496 REGISTRANTS AND SPEAKERS. THE 45TH ANNUAL MEETING WAS HELD IN NOVEMBER 2024 IN AUSTIN, TEXAS...

Read more

ANNUAL MEETING AND AWARDS THE 46TH ANNUAL MEETING WAS HELD IN PHOENIX, ARIZONA AND WAS ATTENDED BY 1,496 REGISTRANTS AND SPEAKERS. THE 45TH ANNUAL MEETING WAS HELD IN NOVEMBER 2024 IN AUSTIN, TEXAS AND WAS ATTENDED BY 1,473 REGISTRANTS AND SPEAKERS. THE MEETING INCLUDED EDUCATIONAL COURSES AND SYMPOSIA ON TOPICS OF RESEARCH AND ISSUES TO THE VARIOUS FIELDS OF TOXICOLOGY.

Program 2
Expenses: $277,199 Revenue: $339,967

EDUCATION AND INFORMATION ACT HELD FOUR COURSES DURING 2025 AND 2024.BIOLOGICS NONCLINICAL DRUG DEVELOPMENT - THIS COURSE PROVIDES AS COMPREHENSIVE OVERVIEW OF REGULATORY AND TOXICOLOGIC...

Read more

EDUCATION AND INFORMATION ACT HELD FOUR COURSES DURING 2025 AND 2024.BIOLOGICS NONCLINICAL DRUG DEVELOPMENT - THIS COURSE PROVIDES AS COMPREHENSIVE OVERVIEW OF REGULATORY AND TOXICOLOGIC CONSIDERATIONS IN THE DEVELOPMENT OF BIOLOGICS. THE PRINCIPLES AND METHODOLOGIES USED IN NONCLINICAL SAFETY ASSESSMENTS ARE DEMONSTRATED FOR ALL STAGES OF DRUG DEVELOPMENT. IN 2025, THE COURSE WAS ATTENDED BY 102 PARTICIPANTS AND SPEAKERS. TOXICOLOGY FOR PHARMACEUTICAL AND REGULATORY SCIENTISTS THIS COURSE WAS ATTENDED BY 66 PARTICIPANTS IN 2025 AND 62 PARTICIPANTS IN 2024. THIS COURSE PROVIDED A BASIC TRAINING IN TOXICOLOGY. USING PHARMACEUTICAL DEVELOPMENTS AS EXAMPLES, PARTICIPANTS OBTAINED AN OVERALL UNDERSTANDING OF THE PRINCIPLES OF TOXICOLOGY AND NONCLINICAL SAFETY EVALUATION.PATHOLOGY FOR NONPATHOLOGISTS THIS COURSE IS HELD EVERY OTHER YEAR AND LECTURES ARE GIVEN BY HIGHLY RESPECTED PATHOLOGISTS HAVING CURRENT AND RELEVANT EXPERIENCE IN TOXICOLOGY PATHOLOGY. IN 2025, THE COURSE WAS NOT HELD. IN 2024, THE COURSE WAS ATTENDED BY 33 PARTICIPANTS. THIS COURSE'S LECTURES COVERED ANATOMY AND PHYSIOLOGY, SPONTANEOUS AND CHEMICALLY INDUCED PATHOLOGICAL CHANGES, AND CLINICAL PATHOLOGY.ADVANCED COMPREHENSIVE TOXICOLOGY THIS COURSE WAS ATTENDED BY 60 IN 2025 AND WAS ATTENDED BY 67 PARTICIPANTS IN 2024. IN THIS INTENSIVE COURSE, ATTENDEES WERE PROVIDED DETAILED DESCRIPTIONS OF PRINCIPLES OF TOXICOLOGY, EFFECTS OF XENOBIOTICS ON ORGAN SYSTEMS, MECHANISMS OF TOXICITY, RISK ASSESSMENT, AND REGULATORY TOXICOLOGY.PRACTICAL REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY - THIS COURSE WAS NOT HELD IN 2025 OR 2024. THIS COURSE PROVIDED A BASIC UNDERSTANDING IN REPRODUCTIVE AND DEVELOPMENTAL BIOLOGY AND PRINCIPLES OF VARIOUS TESTING APPROACHES FOR REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, WITH A STRONG EMPHASIS ON THE PRACTICAL APPLICATION OF THESE PRINCIPLES AND INTERPRETATION OF NONCLINICAL SAFETY DATA AS WELL AS RISK ASSESSMENT.ACT CONTINUED PROMOTING ITS RECORDED ELEARNING SERIES, "BASIC TOPICS IN TOXICOLOGY ELEARNING AND "SPECIALTY TOPICS ELEARNING, AND "SPECIALTY ONCOLOGY BIOTHERAPEUTICS, AND "REGULATORY AND NONCLINICAL CONSIDERATIONS FOR THE DEVELOPMENT OF CNS/NEUROLOGY THERAPEUTICS." THESE ELEARNING SERIES BEGAN IN PRIOR YEARS AND HAD A FEE TO PARTICIPATE. ACT ALSO LAUNCHED A NEW ELEARNING SERIES IN 2025, "BACK TO BASICS: SPECIALTY TOXICOLOGY STUDIES." ACT CONTINUED TO HOST FREE QUARTERLY WEBINARS AND PODCASTS IN 2025 ON CURRENT TOPICS IN TOXICOLOGY, INCLUDING PRIMARILY DRUG AND CHEMICAL SAFETY ASSESSMENTS. PRESENTERS WERE EXPERTS IN THEIR FIELD, WITH BACKGROUNDS IN GOVERNMENT, INDUSTRY, OR ACADEMIA.

Program 3
Expenses: $72,462 Revenue: $70,385

PUBLICATIONS EACH YEAR, ACT PUBLISHES SIX ISSUES OF "INTERNATIONAL JOURNAL OF TOXICOLOGY AND THREE SUPPLEMENTS, WHICH ARE USED TO DISSEMINATE INFORMATION ON ISSUES AND CONCERNS RELATING TO THE FIELD...

Read more

PUBLICATIONS EACH YEAR, ACT PUBLISHES SIX ISSUES OF "INTERNATIONAL JOURNAL OF TOXICOLOGY AND THREE SUPPLEMENTS, WHICH ARE USED TO DISSEMINATE INFORMATION ON ISSUES AND CONCERNS RELATING TO THE FIELD OF TOXICOLOGY TO ITS MEMBERS. ACT ALSO PUBLISHES A QUARTERLY MEMBERSHIP NEWSLETTER, WHICH DISSEMINATES INFORMATION ON ACT'S ACTIVITIES, MESSAGES FROM THE BOARD OF DIRECTORS, AND A SCHEDULE OF EVENTS TO ITS MEMBERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $277,339
Program Service Revenue $2,300,307
Investment Income $499,237
Other Revenue $182,239
TOTAL REVENUE $3,259,122

Expense Breakdown

Grants Paid $63,425
Salaries & Benefits $0
Fundraising Expenses $196,992
Program Expenses $1,601,849
Other Expenses $2,510,632
TOTAL EXPENSES $2,574,057

Year-over-Year Comparison

2025 2024 Change
Revenue $3,259,122 $2,782,991 +0.2%
Expenses $2,574,057 $2,569,607 +0.0%
Net Income $685,065 $213,384 +2.2%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
15
Independent Members
15
Employees
N/A
Volunteers
160

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
10
$0
Total Directors
19
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
PATRICIA RYAN PRESIDENT-ELECT (THRU NOV)/PRESIDENT (FROM DEC) 4.00
Officer Director
$0 $0 $0
JEFFREY TEPPER PRESIDENT (THRU NOV)/PAST PRESIDENT (FROM DEC) 5.00
Officer Director
$0 $0 $0
PEYTON MYERS VP (THRU NOV)/PRESIDENT-ELECT (FROM DEC) 4.00
Officer Director
$0 $0 $0
THOMAS STEINBACH VICE PRESIDENT (FROM DEC) 2.00
Officer Director
$0 $0 $0
WILLIAM BROCK PAST PRESIDENT (THRU NOV) 5.00
Officer Director
$0 $0 $0
KRISTINA DESMET SECRETARY 2.00
Officer Director
$0 $0 $0
ALAN BROWN TREASURER (THRU NOV) 4.00
Officer Director
$0 $0 $0
CHARLES MATTIS TREASURER (FROM DEC) 4.00
Officer Director
$0 $0 $0
RONNIE YEAGER COUNCILOR (THRU NOV) 2.00
Director
$0 $0 $0
MARIE FORTIN COUNCILOR (THRU NOV) 2.00
Director
$0 $0 $0
KRISTA GREENWOOD COUNCILOR 2.00
Director
$0 $0 $0
ANDREA KIM COUNCILOR 2.00
Director
$0 $0 $0
LEANNE BEDARD COUNCILOR 2.00
Director
$0 $0 $0
MICHAEL DORATO COUNCILOR 2.00
Director
$0 $0 $0
NANCY BORDELON COUNCILOR 2.00
Director
$0 $0 $0
JULIE WHITE COUNCILOR 2.00
Director
$0 $0 $0
PARAMITA MOOKHERJEE COUNCILOR 2.00
Director
$0 $0 $0
PEDRO DEL VALLE COUNCILOR 2.00
Director
$0 $0 $0
PALLAVI LIMAYE COUNCILOR 2.00
Director
$0 $0 $0
NANCY ROLLMAN EXECUTIVE DIRECTOR (THRU OCT) 40.00
Officer
$0 $0 $0
ELISA TURNER EXECUTIVE DIRECTOR (FROM NOV) 40.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $3,259,122 $2,574,057 $8,385,806 $685,065
2024 No data No data No data No data
2023 $2,523,822 $2,438,775 $7,016,530 $85,047
2022 $2,400,246 $2,191,658 $6,089,478 $208,588
2021 $2,341,711 $1,457,915 $7,238,636 $883,796
2020 $1,829,609 $1,574,643 $6,141,578 $254,966
2019 $2,293,046 $2,090,312 $5,350,189 $202,734
2018 $1,936,168 $1,858,736 $4,591,312 $77,432
Explore More Nonprofits
Top 100 Nonprofits in Virginia Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare AMERICAN COLLEGE OF TOXICOLOGY with other nonprofits in Virginia and across the country.